Position in VCEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,761,501
+$2,301,774 QoQ
Shares Held
151,978
+9.6% QoQ
Ownership
0.297%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#59
of 317 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEGALL BRYANT & HAMILL, LLC holds $322,746,195 across 29 Biotechnology names. VCEL ranks #18 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
214,724 | $26,320,867 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
317,924 | $24,883,911 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
65,211 | $24,236,972 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
271,735 | $22,165,423 | |
| 5 | TECH |
BIO-TECHNE Corp
|
312,035 | $22,045,272 | |
| 6 | CYTK |
Cytokinetics Inc
|
257,063 | $21,899,196 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
178,980 | $20,953,188 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
37,072 | $18,414,774 |
All Filings in VCEL
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,761,501 | 151,978 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,459,727 | 138,630 | Shares | Sole | 2026-05-22 | |
| 2025-12-31 | $5,420,405 | 150,525 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,321,963 | 137,336 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,748,292 | 135,095 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,342,484 | 74,910 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $5,344,170 | 97,326 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,872,861 | 115,334 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $3,546,661 | 77,303 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,789,709 | 72,851 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,473,862 | 97,553 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,669,164 | 79,629 | Shares | Sole | 2023-11-09 | |
| No filing history on record for this holder in this stock. | ||||||